World's Best Scientists 2026 revealed!

D-Index & Metrics

Mathematics

D-Index
48
Citations
8085
World Ranking
1215
National Ranking
539

Research.com Recognitions

  • 2017 - Fellow of the American Statistical Association (ASA)

Overview

Ying Yuan is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans the field of Medicine with a significant focus on Oncology and Statistics. Yuan's work integrates clinical and statistical methodologies, particularly in the design and analysis of clinical trials and cancer treatment.

The main fields of study include:

  • Medicine

Subfields prominently covered in Yuan's research are:

  • Statistics and Probability
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Management Science and Operations Research

The key research topics for Yuan are:

  • Statistical Methods in Clinical Trials
  • Optimal Experimental Design Methods
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer Immunotherapy and Biomarkers
  • Glioma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Ovarian cancer diagnosis and treatment

Yuan's recent notable publications include:

  • "Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study" (2020) published in The Lancet Oncology
  • "Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial" (2021) published in Journal of Clinical Oncology
  • "BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies" (2020) published in JCO Precision Oncology
  • "Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck" (2021) published in Clinical Cancer Research
  • "Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer" (2020) published in American Journal of Obstetrics and Gynecology

Common co-authors working frequently with Yuan include:

  • Shannon N. Westin
  • Bryan Fellman
  • Karen H. Lu
  • Amir A. Jazaeri
  • Ruitao Lin

Typical publication venues for Yuan's work are:

  • Journal of Clinical Oncology
  • Neuro-Oncology
  • Clinical Cancer Research
  • Biometrics
  • Statistics in Biopharmaceutical Research

Yuan's contributions to statistical science were recognized in 2017 with election as a Fellow of the American Statistical Association.

Best Publications

  • Bayesian Mediation Analysis

    Ying Yuan;David P. MacKinnon

  • IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

    Adriana Olar;Khalida M. Wani;Kristin D. Alfaro-Munoz;Lindsey E. Heathcock

  • Bayesian optimal interval designs for phase I clinical trials

    Suyu Liu;Ying Yuan

  • Joint regression analysis of correlated data using Gaussian copulas.

    Peter X.K. Song;Mingyao Li;Ying Yuan

  • A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment

    Leslie R. Schover;Andrea L. Canada;Ying Yuan;Dawen Sui

  • Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells

    Dimpy Koul;Jun Fu;Ruijun Shen;Tiffany A. LaFortune

  • Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials

    Ying Yuan;Kenneth R. Hess;Susan G. Hilsenbeck;Mark R. Gilbert

  • Bayesian dose finding in oncology for drug combinations by copula regression

    Guosheng Yin;Ying Yuan

  • Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials

    Guosheng Yin;Ying Yuan

  • Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials

    Fangrong Yan;Sumithra J. Mandrekar;Ying Yuan

  • Sample size determination for mediation analysis of longitudinal data

    Haitao Pan;Suyu Liu;Danmin Miao;Ying Yuan

  • Bayesian Quantile Regression for Longitudinal Studies with Nonignorable Missing Data

    Ying Yuan;Guosheng Yin

  • A Bayesian basket trial design using a calibrated Bayesian hierarchical model.

    Yiyi Chu;Ying Yuan

  • A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents

    Guosheng Yin;Ying Yuan

  • Bayesian dose finding by jointly modelling toxicity and efficacy as time-to-event outcomes

    Ying Yuan;Guosheng Yin

  • Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.

    Renata Ferrarotto;Moran Amit;Priyadharsini Nagarajan;M. Laura Rubin

  • BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies

    Ruitao Lin;Yanhong Zhou;Fangrong Yan;Daniel Li

  • Accuracy, Safety, and Reliability of Novel Phase I Trial Designs

    Heng Zhou;Ying Yuan;Lei Nie

  • BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints

    Heng Zhou;J. Jack Lee;Ying Yuan

  • Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials.

    Ying Yuan;Ruitao Lin;Ruitao Lin;Daniel Li;Lei Nie

  • Using Data Augmentation to Facilitate Conduct of Phase I–II Clinical Trials with Delayed Outcomes

    Ick Hoon Jin;Suyu Liu;Peter F. Thall;Ying Yuan

  • Sequential continual reassessment method for two‐dimensional dose finding

    Ying Yuan;Guosheng Yin

Frequent Co-Authors

Guosheng Yin
Guosheng Yin University of Hong Kong
Mark R. Gilbert
Mark R. Gilbert National Institutes of Health
Karen H. Lu
Karen H. Lu The University of Texas MD Anderson Cancer Center
Peter F. Thall
Peter F. Thall The University of Texas MD Anderson Cancer Center
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Kenneth Aldape
Kenneth Aldape National Institutes of Health
Roderick J. A. Little
Roderick J. A. Little University of Michigan–Ann Arbor
Russell Broaddus
Russell Broaddus University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Mathematics, branching into related online degrees can enhance career opportunities in business, finance, and technology. Many professionals leverage their math skills by pursuing an easiest online mba program to gain leadership and management expertise without sacrificing flexibility.

For those seeking more specialized expertise, the best 1 year dba program online offers an accelerated path for data-driven decision making and advanced business analytics. This degree complements mathematical backgrounds with practical business applications.

The financial sector is another popular direction. Pursuing the cheapest online master's in finance provides rigorous training in financial modeling and quantitative analysis, skills highly valued in investment banking and financial management roles.

Additionally, for students prioritizing quick graduation timelines, the fastest online mba programs enable accelerated completion while building strong strategic and analytical capabilities. Combining math proficiency with these credentials opens diverse and rewarding career pathways.

Best Scientists Citing Ying Yuan

Trending Scientists